- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: ARX788 Cemiplimab
Total 164 results
-
Caigang LiuJiangsu HengRui Medicine Co., Ltd.Active, not recruiting
-
Kissei Pharmaceutical Co., Ltd.CompletedIdiopathic Thrombocytopenic PurpuraJapan
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingMetastatic Lung Non-Small Cell Carcinoma | Stage IV Lung Cancer AJCC v8 | Metastatic Malignant Neoplasm in the BrainUnited States
-
HotSpot Therapeutics, IncRecruitingSolid Tumor, Adult | Relapsed Cancer | Refractory CancerUnited States
-
SanofiActive, not recruitingMalignant Melanoma | Squamous Cell Carcinoma of SkinGermany, Spain, France, Chile, United States, Australia, Italy
-
Regeneron PharmaceuticalsSanofiWithdrawn
-
Replimune Inc.Regeneron PharmaceuticalsActive, not recruitingCutaneous Squamous Cell Carcinoma | Advanced Cutaneous Squamous Cell Carcinoma | Metastatic Cutaneous Squamous Cell CarcinomaSpain, United States, France, Australia, Germany, Canada, Greece, Bulgaria, Italy, Poland
-
Rigel PharmaceuticalsCompleted
-
The Netherlands Cancer InstituteGenzyme, a Sanofi CompanyRecruitingCarcinoma, Non-Small-Cell LungNetherlands
-
Vyriad, Inc.Regeneron PharmaceuticalsRecruitingMelanoma | Head and Neck Squamous Cell Carcinoma | Colo-rectal CancerUnited States, Brazil
-
Regeneron PharmaceuticalsSanofiActive, not recruitingNonsmall Cell Lung Cancer | Carcinoma,Non-Small-Cell Lung | Non-small-cell Lung Carcinoma | Lung Carcinomas, Non-Small-CellSpain, Australia, Belarus, Brazil, Bulgaria, Chile, China, Colombia, Czechia, Georgia, Greece, Hungary, Jordan, Lebanon, Malaysia, Mexico, Philippines, Poland, Romania, Russian Federation, Taiwan, Thailand, Turkey, Ukraine
-
Rigel PharmaceuticalsCompletedImmune Thrombocytopenic PurpuraSpain, United States, Australia, Poland, United Kingdom, Canada, Czechia, Bulgaria, Romania, Austria, Denmark, Hungary, Italy, Netherlands, Norway
-
Maia BiotechnologyRecruitingCarcinoma, Non-Small-Cell LungPoland, Australia, Bulgaria, Hungary
-
Rigel PharmaceuticalsCompletedPurpura, Thrombocytopenic, IdiopathicUnited States
-
Servier Bio-Innovation LLCRegeneron Pharmaceuticals; Institut de Recherches Internationales ServierNot yet recruitingNon-small Cell Lung Cancer (NSCLC)Hong Kong, United States, Australia
-
Regeneron PharmaceuticalsRecruitingNon-small Cell Lung CancerKorea, Republic of, United States, Malaysia, Australia, Georgia, Israel, Canada
-
Jason J. Luke, MDRecruitingMelanoma | Cervical Cancer | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | NSCLC | Advanced Solid Tumors | Cholangiocarcinoma | Bladder Cancer | Renal Cancer | Anal Cancer | Merkel Cell Carcinoma | HNSCCUnited States
-
Rigel PharmaceuticalsCompletedImmune Thrombocytopenic PurpuraSpain, Norway, Poland, Czechia, Germany, United States, Austria, Bulgaria, Romania
-
H. Lee Moffitt Cancer Center and Research InstituteRegeneron PharmaceuticalsActive, not recruitingHormone Receptor-positive Breast CancerUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)RecruitingStage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 | Stage IV Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 | Advanced Dedifferentiated Liposarcoma | Metastatic Dedifferentiated Liposarcoma | Locally Advanced Dedifferentiated Liposarcoma | Unresectable Dedifferentiated...United States
-
Rigel PharmaceuticalsWithdrawnSystemic Lupus Erythematosus
-
Krzysztof MisiukiewiczRegeneron PharmaceuticalsRecruitingLocally Advanced Head and Neck Squamous Cell CarcinomaUnited States
-
Shengjing HospitalRecruiting
-
Rigel PharmaceuticalsCompletedImmune Thrombocytopenic PurpuraUnited States, Australia, United Kingdom, Canada, Italy, Denmark, Hungary, Netherlands
-
Novartis PharmaceuticalsCompletedBrain and Central Nervous System TumorsUnited States
-
Johns Hopkins UniversityCompletedCutaneous Toxicity From ICI TherapyUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingRefractory Chronic Myelomonocytic Leukemia | Refractory Myelodysplastic SyndromeUnited States
-
OncoResponse, Inc.RecruitingMelanoma | Cancer | Non Small Cell Lung Cancer | Metastatic Cancer | Advanced Solid Tumor | Leiomyosarcoma | Head and Neck Squamous Cell Carcinoma | Liposarcoma | Malignant Neoplasm | Tumor, SolidUnited States
-
QuantumLeap Healthcare CollaborativeRecruitingBreast Cancer | Breast Neoplasms | Breast Tumors | HER2-positive Breast Cancer | Angiosarcoma | Locally Advanced Breast Cancer | HER2-negative Breast Cancer | TNBC - Triple-Negative Breast Cancer | Hormone Receptor Positive Tumor | Hormone Receptor Negative Tumor | Early-stage Breast CancerUnited States
-
Inovio PharmaceuticalsActive, not recruiting
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI); Genzyme, a Sanofi Company; American Association...CompletedMetastatic Pancreatic CancerUnited States
-
SanofiRecruitingPlasma Cell MyelomaCzechia, Australia, Chile, France, Spain, United States, Brazil, China, Greece, Japan, Korea, Republic of, Sweden, Taiwan, Finland, Italy, Russian Federation
-
Rigel PharmaceuticalsNo longer availableImmune Thrombocytopenic Purpura
-
H. Lee Moffitt Cancer Center and Research InstituteRegeneron Pharmaceuticals; Genzyme, a Sanofi CompanyRecruitingMetastatic Uveal MelanomaUnited States
-
Regeneron PharmaceuticalsRecruitingMelanomaUnited States, Australia, Spain, United Kingdom, Canada, Brazil, Mexico, Germany, Ireland, South Africa, France, Israel, Georgia, Turkey, Italy, Poland, Chile, Argentina, Belgium, Czechia, Romania, Greece
-
H. Lee Moffitt Cancer Center and Research InstituteRecruitingMerkel Cell Carcinoma | Cutaneous Melanoma | Cutaneous Squamous Cell CarcinomaUnited States
-
Regeneron PharmaceuticalsRecruitingMelanomaUnited States, Spain, Germany, Mexico, Turkey, Canada, Austria, Netherlands, United Kingdom, Italy, Georgia, France, Brazil, Romania, Czechia, Argentina, Australia, Ireland, Chile, Hungary, South Africa, Belgium, Poland, Peru
-
BioNTech SERecruitingNon-Small Cell Lung CancerSpain, Germany, Turkey, United States, Hungary, United Kingdom, Poland
-
Rigel PharmaceuticalsCompletedIGA NephropathyUnited States, United Kingdom, Hong Kong, Taiwan, Austria, Germany
-
Rigel PharmaceuticalsCompletedWarm Antibody Autoimmune Hemolytic AnemiaUnited States, Canada
-
University of Southern CaliforniaNational Cancer Institute (NCI)RecruitingAdvanced Malignant Skin Neoplasm | Metastatic Malignant Skin NeoplasmUnited States
-
Inimmune CorporationAvance Clinical Pty Ltd.Not yet recruiting
-
Thomas Jefferson UniversityRecruitingLocally Advanced Basal Cell CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterRegeneron PharmaceuticalsRecruitingHead and Neck Cancer | Head and Neck Squamous Cell Carcinoma | HNSCC | Head Cancer | Neck Cancer | Head Cancer NeckUnited States
-
Duke UniversityRegeneron PharmaceuticalsNot yet recruitingNon Small Cell Lung Cancer
-
Gulam ManjiRegeneron Pharmaceuticals; BioLine RxRecruitingAdenocarcinoma | Pancreatic Cancer | Adenocarcinoma of the PancreasUnited States
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
Rigel PharmaceuticalsWithdrawn
-
Jules Bordet InstituteRecruitingMelanoma | Renal Cell Carcinoma | Breast Cancer | Head and Neck Cancer | Small Cell Lung Cancer | Hepatocellular Carcinoma | Non Small Cell Lung Cancer | Mesothelioma, Malignant | Bladder Cancer | Gastrointestinal Cancer | Merkel Cell Carcinoma | Non-melanoma Skin Cancer | MSI-H Colorectal CancerBelgium